Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
Fiscal year end changed to December 31st
2025
Q1 2025
Quarter Ended Dec 31, 2024
2024
FY 2024
Fiscal Year Ended Sep 30, 2024
Q3 2024
Quarter Ended Jun 30, 2024
Q2 2024
Quarter Ended Mar 31, 2024
Q1 2024
Quarter Ended Dec 31, 2023
2023
FY 2023
Fiscal Year Ended Sep 30, 2023
Q3 2023
Quarter Ended Jun 30, 2023
Q2 2023
Quarter Ended Mar 31, 2023
Q1 2023
Quarter Ended Dec 31, 2022
2022
FY 2022
Fiscal Year Ended Sep 30, 2022
Q3 2022
Quarter Ended Jun 30, 2022
Q2 2022
Quarter Ended Mar 31, 2022
Q1 2022
Quarter Ended Dec 31, 2021
2021
FY 2021
Fiscal Year Ended Sep 30, 2021
Q3 2021
Quarter Ended Jun 30, 2021
Q2 2021
Quarter Ended Mar 31, 2021
Q1 2021
Quarter Ended Dec 31, 2020
2020
FY 2020
Fiscal Year Ended Sep 30, 2020
Q3 2020
Quarter Ended Jun 30, 2020